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Abstract
Background: Protein Ser/Thr phosphatase 5 (PP5) and its Saccharomyces cerevisiae homolog
protein phosphatase T1 (Ppt1p) each contain an N-terminal domain consisting of several
tetratricopeptide repeats (TPRs) and a C-terminal catalytic domain that is related to the catalytic
subunits of protein phosphatases 1 and 2A, and calcineurin. Analysis of yeast Ppt1p could provide
important clues to the function of PP5 and its homologs, however it has not yet been characterized
at the biochemical or cellular level.
Results: The specific activity of recombinant Ppt1p toward the artificial substrates 32P-myelin basic
protein (MBP) and 32P-casein was similar to that of PP5. Dephosphorylation of 32P-MBP, but not
32P-casein, was stimulated by unsaturated fatty acids and by arachidoyl coenzyme A. Limited
proteolysis of Ppt1p removed the TPR domain and abrogated lipid stimulation. The remaining
catalytic fragment exhibited a two-fold increase in activity toward 32P-MBP, but not 32P-casein.
Removal of the C terminus increased Ppt1p activity toward both substrates two fold, but did not
prevent further stimulation of activity toward 32P-MBP by lipid treatment. Ppt1p was localized
throughout the cell including the nucleus. Levels of PPT1 mRNA and protein peaked in early log
phase growth.
Conclusions: Many characteristics of Ppt1p are similar to those of PP5, including stimulation of
phosphatase activity with some substrates by lipids, and peak expression during periods of rapid
cell growth. Unlike PP5, however, proteolytic removal of the TPR domain or C-terminal truncation
only modestly increased its activity. In addition, C-terminal truncation did not prevent further
activation by lipid. This suggests that these regions play only a minor role in controlling its activity
compared to PP5. Ppt1p is present in both the nucleus and cytoplasm, indicating that it may function
in multiple compartments. The observation that Ppt1p is most highly expressed during early log
phase growth suggests that this enzyme is involved in cell growth or its expression is controlled by
metabolic or nutritional signals.
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Background

Results

Mammalian protein phosphatase 5 (PP5) and its homolog protein phosphatase T1 (Ppt1p) from the yeast
Saccharomyces cerevisiae contain a catalytic domain structurally related to the catalytic subunits of PP1, PP2A and
PP2B, and an N-terminal domain consisting of multiple
tetratricopeptide repeats (TPRs) not found in other members of this family of phosphatases [1–3]. Homologs have
also been identified in Xenopus laevis [4], Neurospora crassa
[5], Drosophila melanogaster [6], Trypanosoma brucei [7],
Plasmodium falciparum [8,9], and cauliflower [10], and homologs for Caenorhabditis elegans, Schizosaccharomyces
pombe and Arabidopsis thaliana are predicted (accession
number CAB60937, CAA17690 and AAD21727,
respectively).

Comparison of Ppt1p and PP5 activity and response to lipid treatment
Recombinant Ppt1p expressed as a GST-fusion protein,
then affinity purified and released from GST by thrombin
cleavage yielded a single band of the expected molecular
weight, 58 kDa (Fig. 1A). When assayed side-by-side, the
basal specific activities for recombinant Ppt1p and PP5
were similar toward the artificial substrates 32P-MBP and
32P-casein, respectively (Fig. 1B). Like PP5, the dephosphorylation of 32P-MBP by Ppt1p was stimulated by arachidonic acid and other unsaturated fatty acids, but lipids
lacking either a double bond or a carboxylate group were
not effective (Table 1).

Protein phosphatase 5 has been implicated in the control
of cell proliferation, in hormonal signal transduction, and
in hsp90 chaperone function [3,11–17]. However little is
known about the regulation of PP5 or its specific role in
these pathways, and only one physiological substrate for
PP5 has been identified to date, the apoptosis signaling kinase ASK 1 [13]. PP5 can be activated by lipid in vitro, and
removal of the TPR domain or the C terminus generates
an active, lipid insensitive form of the enzyme [18–21].
PP5 phosphatase activity is also altered by hCRY2 and a
fragment of hsp90 in vitro [21,22]. These findings suggest
that PP5 may be autoinhibited and that the binding of
protein partners or lipids to the TPR domain could potentially control PP5 activity in cells, however no reports have
yet documented how PP5 is regulated in vivo. The activity
of PP5 homologs from cauliflower, T. brucei and P. falciparum is stimulated by polyunsaturated fatty acids in vitro
[7–10] and removal of the TPR domain from P. falciparum
PP5 increases activity to the same extent as lipid treatment
[8,9]. This suggests that the TPR domain plays a similar inhibitory role for all PP5 homologs.
Genetic analyses in S. cerevisiae have yielded few clues
about the function of Ppt1p. Budding yeast lacking PPT1
do not exhibit obvious growth defects or detectable phenotypes [2]. Disruption of PPT1 together with one of the
other known phosphatases in budding yeast also reveals
no obvious phenotype [23]. Thus, if Ppt1p has an essential function in S. cerevisiae, more than one other phosphatase can also carry out this role. In this report we have
characterized the activity of recombinant Ppt1p, analyzed
its expression at the level of protein and mRNA, and localized Ppt1p in yeast. Ppt1p can be activated by lipid, is
most highly expressed in early log phase growth, and is
present throughout the cell.

In the case of pNPP hydrolysis, others have reported both
saturated and unsaturated fatty acyl coenzyme A esters
stimulate PP5 activity, with concentrations required for
half-maximal stimulation approximately 10-fold lower
than those of their corresponding free fatty acids [21]. We
therefore tested whether a saturated fatty acyl coenzyme A
ester could also stimulate Ppt1p. Ppt1p activity toward
32P-MBP was stimulated by arachidoyl coenzyme A in a
concentration range similar to that observed for AA, with
half-maximal stimulation occurring at approximately 50
µM for arachidoyl coenzyme A and 75 µM for AA. However, in contrast to AA stimulation, Ppt1p activity dropped
off sharply at 80 µM arachidoyl coenzyme A and higher.
Similar results were observed for PP5 (data not shown).
This suggests that double bonds are not required to observe the effect of fatty acyl coenzyme A esters.
Unlike PP5, the activity of Ppt1p toward 32P-casein was
not stimulated by AA, arachidoyl coenzyme A, or linoleoyl coenzyme A over a range in concentration from 10–
500 µM (Fig. 1B and data not shown). Other unsaturated
fatty acids also failed to stimulate Ppt1p activity with this
substrate (Table 1). These data indicate that Ppt1p is stimulated by polyunsaturated fatty acids, as well as by a saturated fatty acyl coenzyme A derivative, toward some but
not all substrates dephosphorylated by PP5.
Limited proteolysis of Ppt1p
Removal of the TPR domain of PP5 by limited proteolysis
increases enzyme activity and the TPR domain binds lipid
[7–9,19,20]. Using conditions similar to those employed
with PP5, digestion of Ppt1p with trypsin in the absence
of lipid produced a 44 kDa catalytic fragment that was stable for at least 30 min and a 20 kDa fragment that was degraded within 30 min (Fig. 2A). N-terminal sequence
analysis showed that these fragments are derived from the
catalytic and the TPR domains, respectively (Fig. 2A,2B).
The crystal structure of the PP5 TPR domain revealed three
TPRs followed by an extended α helix [24], however
Ppt1p was originally proposed to contain one additional
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Figure 1
Comparison of the specific activities and response to lipid of Ppt1p and PP5. (A) Recombinant Ppt1p (lane 1) and
Ppt1p (1–504) (lane 2) were expressed in Escherichia coli, purified by GST-agarose chromatography and cleaved with thrombin.
Samples containing approximately 7.5 µg of protein were resolved by SDS-PAGE on a 10% polyacrylamide gel and visualized by
Coomassie staining. The migration of molecular weight standards is indicated to the left. (B) Phosphatase activity of Ppt1p or
PP5 was assayed for 10 min at 30°C in the absence (䊐) or presence (■) of 250 µM AA using 10 µM 32P-MBP or 32P-casein as
substrate. Data are the average ± S.D. from assays performed in triplicate. Three independent experiments performed under
similar conditions yielded similar results.
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Table 1: Effect of various fatty acids on recombinant Ppt1p activity

Lipid added

Arachidonic acid
Arachidic acid
Arachidonyl alcohol
Arachidonic methyl ester
Oleic acid
Linoleic acid
Palmitoleic acid

Relative Activitya

Carbon chain

20:4
20:0
20:4
20:4
18:1
18:2
16:1

TPR protection

Casein

MBP

1.3 ± 0.0
0.6 ± 0.1
0.7 ± 0.1
0.7 ± 0.1
1.0 ± 0.1
1.0 ± 0.1
1.0 ± 0.1

13 ± 0.5
0.8 ± 0.3
1.1 ± 0.1
0.6 ± 0.2
16 ± 1.0
21 ± 1.3
20 ± 2.1

+
+
+
+

Phosphatase assays included Ppt1p that was incubated in the presence of various lipids each at a final concentration of 250 µM. Assays also contained either 32P-casein or 32P-MBP. Data are presented as the average activity relative to control in the absence of lipid ± S.D. from a single assay
performed in triplicate. This experiment was repeated three times with similar results. The control values for recombinant Ppt1p were as follows:
79 ± 1.9 nmol Pi released minute-1 mg-1 for 32P-casein; 35 ± 10 nmol Pi released minute-1 mg-1 for 32P-MBP. A positive score for TPR protection
indicates the sustained presence of multiple proteolytic fragments in the size range of 14 to 16 kDa after either trypsin or subtilisin digestion when
compared to the control digest containing vehicle. aRatio of phosphatase activity in the presence of 250 µM of the lipid indicated to the phosphatase
activity without lipid.

TPR [2]. The pattern of proteolysis and sites of cleavage for
Ppt1p are very similar to those seen with PP5 under these
same conditions [19]. This indicates that Ppt1p also contains an accessible region linking the TPR and catalytic domains and is most consistent with the presence of three
TPRs in Ppt1p. Limited tryptic proteolysis in the presence
of 250 µM AA generated a distinct pattern of fragmentation (Fig. 2A). A 20 kDa fragment was observed at early
times, but a series of four fragments ranging from 14–16
kDa appeared between 10 and 30 min as the amount of
the 20 kDa fragment decreased. These fragments, which
are derived from the TPR domain, were not observed in
the absence of AA, suggesting that lipid binding alters the
conformation of this domain and its susceptibility to proteolysis. A similar change in susceptibility to proteolysis
upon lipid binding was observed with PP5 [19]. As with
PP5, only lipids that stimulated 32P-MBP dephosphorylation slowed degradation of the 20 kDa TPR fragment (Table 1).
Removal of the TPR domain from Ppt1p by trypsin treatment had no effect on its activity toward 32P-casein, but
increased activity toward 32P-MBP approximately two
fold (Fig. 2C). AA did not stimulate 32P-MBP dephosphorylation by Ppt1p after removal of the TPR domain (data
not shown). Thus, lipids that activate Ppt1p alter the sensitivity of the TPR domain to proteolysis, and removal of
the TPR domain causes a loss of the response of Ppt1p to
lipid. However, removal of the TPR domain only modestly increases Ppt1p activity, in contrast to the 5–25 fold elevation reported after TPR removal from PP5 [19,20].
Although we cannot rule out the possibility that proteolyzed Ppt1p is unresponsive to lipid because it is unstable, the observations that the catalytic fragment remains

undegraded and control activity is not decreased argue
against this possibility. Alternatively, an inhibitory element in the linker region may remain after TPR domain
removal.
The effect of C-terminal truncation on Ppt1p activity
Removal of 10–13 residues from the C terminus of PP5 results in a highly active enzyme that is only modestly stimulated by lipid [19]. To examine the role of the C terminus
in controlling Ppt1p phosphatase activity, a similar truncation mutant, Ppt1p (1–504), was expressed and characterized (Fig. 1A and 3). Compared to full-length enzyme
Ppt1p (1–504) exhibited a two-fold increase in control
specific activity with both 32P-casein and 32P-MBP. Lipid
did not stimulate Ppt1p (1–504) toward 32P-casein, but
still increased activity with 32P-MBP 12-fold. In contrast,
C-terminal truncation of PP5 activates the enzyme as extensively as lipid treatment, and little further activation is
seen with lipid [19]. In the case of PP5, subtilisin digestion removed both the TPR domain and the C terminus
[19]. The observation that C-terminal truncation increased Ppt1p activity toward both 32P-casein and 32PMBP, but subtilisin digestion increased activity only toward 32P-MBP (see Fig. 2C) suggests that the C terminus
of Ppt1p remained intact during subtilisin digestion.
However, mass analysis of the subtilisin-derived catalytic
fragment would be required to confirm this.
Expression and localization of HA-Ppt1p in yeast cells
To examine when Ppt1p is expressed and where it is localized, a yeast strain (WHT4-1) was generated in which the
PPT1 gene was replaced with cDNA encoding hemagglutinin-tagged Ppt1p (HA-Ppt1p). Immunoblotting showed
that HA-Ppt1p levels were highest in early log phase, and
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Figure 2
Limited proteolysis of Ppt1p and its effect on Ppt1p activity. (A) Recombinant Ppt1p samples trypsinized in the
absence or presence of 250 µM AA were resolved by electrophoresis on 15% SDS-polyacrylamide gel and visualized by
Coomassie staining. The length of digest (minutes) and the migration of molecular weight standards are indicated. (B) N-terminal sequence analysis of 45 kDa fragments shown in (A) was performed to identify the tryptic cleavage sites within the linker
region between the TPR and catalytic domains. Tryptic cleavage sites are indicated with the inverted triangles. Bold underlined
residues are conserved in both Ppt1p and PP5. (C) Recombinant Ppt1p was digested using either trypsin (T) or subtilisin (S) for
5 minutes in the absence of AA and assayed using either 32P-casein or 32P-MBP in the absence of AA. Data are presented as
activity relative to control, which is the activity of full-length Ppt1p subjected to mock digest and assayed in the absence of AA.
Results represent the mean ± S.E. from three or more independent experiments.
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Figure 3
Effect of C-terminal truncation on Ppt1p activity. (A) Phosphatase activity of full-length Ppt1p (䊐) or the C-terminal
truncation mutant, Ppt1p (1–504) (■), was determined in the absence or presence of 250 µM AA using 32P-casein or 32P-MBP
as substrate. Data are the average ± S.D. of triplicate samples from a single experiment. Similar values were obtained in three
independent experiments performed under the same conditions. (B) C-terminal sequences of Ppt1p and PP5 are aligned to display the truncation sites for Ppt1p (1–504) and PP5 (1–486) [19]. The truncation sites are indicated with the filled triangles.
Bold underlined residues are conserved in both Ppt1p and PP5.
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Figure 4
Expression of HA-Ppt1p as a function of cell growth. (A) An overnight culture of WHT4-1 cells (OD600 nm 5~10) was
used to inoculate fresh medium to OD600 nm 0.2 and the culture grown at 30°C. At the indicated times samples were prepared
and subjected to immunoblotting using anti-HA antibody. The lower panel shows the bottom half of the same blot probed with
anti-Cdc28p antibody. This experiment was performed four times independently with similar results. WT; wild type. (B) The
growth curve was plotted based on direct cell counting using a hemocytometer. The relative amount of HA-Ppt1p was
obtained by taking the ratio of the band intensity of HA-Ppt1p to Cdc28p. (C) Total RNA was isolated at the indicated time
after the inoculation of an overnight culture of W303 cells (OD600 nm 5~10) to OD600 nm 0.2. Twenty micrograms of RNA per
sample were resolved and subjected to Northern analysis with a 32P-labeled PPT1 cDNA probe. The lower panel shows the
same blot probed for yeast actin mRNA. This experiment was repeated four independent times for both W303 and WHT4-1
cells with similar results.
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Figure 5
Localization of HA-Ppt1p in yeast cells during early log phase growth. (A) Yeast cells expressing wild-type Ppt1p
(W303; a, b, c) or HA-Ppt1p (WHT4-1; d, e, f) were subjected to immunocytochemistry using modified ABC amplification.
DAPI was used for nuclear staining. The exposure time for the HA-Ppt1p (green) signal was 5 sec. (B) A spindle pole body protein, Spc42p fused with EGFP (Spc42p-EGFP) was expressed in W303 cells, and localized by both direct green fluorescence of
EGFP (j) and indirect red immunofluorescence (k) using the same method of amplification. The exposure times for the direct
EGFP signal and the indirect immunofluorescence signal were 5 sec and 40 msec, respectively. Wild-type cells (W303) were
used as negative controls for both experiments (a, b, c, and g, h, i). All samples were observed with 1000 × magnification.

then decreased dramatically during the stationary phase
(Fig. 4A,4B). Northern analysis showed that the PPT1
mRNA levels also increased in early log phase and decreased as the cell division decreased upon entering the
stationary phase (Fig. 4C), correlating with protein expression. The pattern of PPT1 gene expression was identical in
wild-type cells and cells expressing HA-Ppt1p, indicating
that the epitope tag did not alter transcription or message
stability (data not shown).
Cells in early log phase growth when PPT1 gene expression was maximal were used to localize HA-Ppt1p. Indirect immunofluorescence was required to detect HA-

Ppt1p. Fluorescence microscopy indicated that HA-Ppt1p
was present throughout the cell, including the nucleus
(Fig. 5A). Localization and staining intensity did not appear to change as a function of bud size or morphology,
suggesting that Ppt1p expression and localization is not
cell cycle dependent.
To confirm that the indirect immunofluorescence procedure did not generate artifacts, the localization of the
spindle pole body protein Spc42p was also examined by
this method. A yeast centromeric plasmid encoding the
fusion protein Spc42p-EGFP was transformed into W303
cells. Direct fluorescence from EGFP and indirect
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immunofluorescence using the amplification protocol
with anti-EGFP antibody were compared. Both signals revealed specific localization of Spc42p-EGFP to the spindle
pole body (Fig. 5B).
When HA-Ppt1p or EGFP-Ppt1p was overexpressed from
the GAL1 promoter in a centromeric or episomal plasmid,
respectively, indirect immunofluorescence of HA-Ppt1p
or direct fluorescence from EGFP-Ppt1p showed that both
proteins were also localized throughout the cell.

Discussion
PP5 and its homologs in other species represent a subfamily of PPP enzymes distinguished by the presence of
an N-terminal domain containing multiple TPR repeats.
Ppt1p from the yeast Saccharomyces cerevisiae was the first
homolog of mammalian PP5 to be described. Thus far, genetic approaches have not revealed functions for budding
yeast Ppt1p. In this report, we have characterized Ppt1p
activity in vitro and examined its expression.
In the case of mammalian PP5, results from lipid stimulation and binding, limited proteolysis and truncation studies taken together suggest the TPR domain and the C
terminus inhibit PP5 activity in a coordinated manner
and that lipid binding to the TPR domain activates the enzyme in vitro [18–20]. In the present study we used assay
conditions for Ppt1p identical to those in which PP5 was
shown to be activated by removal of the TPR or C-terminal regions [19]. Under these conditions Ppt1p is also
stimulated by lipids toward 32P-MBP, and activating lipids slow TPR domain proteolysis. These results indicate
that Ppt1p has a similar domain structure to PP5 and is activated in a similar manner by lipid binding to the TPR domain. Removal of the TPR domain prevents stimulation
by lipid, but only modestly increases Ppt1p activity. Carboxyl-terminal truncation modestly increases Ppt1p activity toward both 32P-MBP and 32P-casein, and does not
prevent further lipid stimulation of 32P-MBP dephosphorylation. These results distinguish Ppt1p from mammalian PP5 and suggest that the C terminus is less important
in controlling Ppt1p activity. Although more work will be
required to determine its role in lipid stimulation, removal of the TPR domain had only a small effect on Ppt1p activation. Ppt1p contains two short stretches of amino
acids, a 15-residue sequence between the linker helix and
the catalytic domain (residues 174–188), and a ten-residue sequence just preceding the extreme C terminus (residues 474–484), that are not found in other PP5
homologs reported thus far ([1–10], and accession numbers CAB60937, CAA17690 and AAD21727). The presence of these additional sequences in Ppt1p may underlie
the differences in the responses of Ppt1p and PP5 to N or
C-terminal truncation. Additional studies will be required

http://www.biomedcentral.com/1471-2121/4/3

to determine if our observations reflect structural and regulatory properties unique to Ppt1p.
Ppt1p and PP5 exhibit similar specific activities toward
32P-casein in the absence of lipid. However Ppt1p activity
toward this substrate was not stimulated by lipids. These
results highlight the fact that PPP enzymes often exhibit
substrate specific effects in vitro and that the use of a single
substrate to study this family of enzymes can be
misleading. Like PP5, the control activity of Ppt1p is low
toward the commonly used artificial substrates such as
32P-casein and 32P-MBP compared to other PPP enzymes
[18]. Thus, it is not clear whether the selective lipid stimulation of Ppt1p toward 32P-MBP reflects a substrate-directed effect, or whether 32P-casein is simply a poor
substrate for Ppt1p. Egloff and colleagues identified seven
acidic surface residues on the catalytic face of PP1c γ that
are replaced by neutral or basic residues in PP2A [25].
They suggest the presence of these acidic residues in PP1c
γ may explain why casein is a good substrate for PP2A, but
not for PP1. Based on a sequence alignment with PP1c γ,
these seven acidic residues are not conserved in Ppt1p. Using the program Modeller [26], a homology model of the
catalytic domain of Ppt1p was built based on three PP1
structures – PDB http://www.pdb.org[27] codes 1FJM
[28], 1IT6 [29] and 1JK7 [30]. This model shows that the
catalytic face of Ppt1p is generally less acidic than that of
PP1c γ and does not indicate the presence of other acidic
residues that could act in the same fashion as those on
PP1c γ. Thus the reason for low Ppt1p activity toward this
acidic substrate may be more complex than can be explained by electrostatic repulsion.
Others have proposed that fatty acyl coenzyme A esters are
potential physiologic regulators of PP5, since these compounds stimulate pNPP hydrolysis by PP5 in vitro at physiologically relevant concentrations and are approximately
10-fold more potent than their free fatty acid counterparts
[21]. Although we confirmed this observation using PP5
and pNPP (data not shown), in our hands similar levels
of AA and arachidoyl coenzyme A were required for halfmaximal stimulation of 32P-MBP dephosphorylation in
the case of both Ppt1p and PP5. Although more work is
required to examine this issue thoroughly, our results suggest that the large differences in potency between free fatty
acids and fatty acyl coenzyme A esters seen using pNPP
may not extend to all protein substrates. In addition, it
will be important to determine if lipids in any form play
a role in the regulation of PP5 or Ppt1p in vivo.
Ppt1p was present in both the nucleus and cytoplasm of
S. cerevisiae. No difference in compartmentalization or
staining intensity in cells was observed as a function of
cell or bud size. This suggests that the level or localization
of Ppt1p is not controlled as a function of cell cycle
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progression. Both nuclear and cytoplasmic localization
have been reported for other PP5 homologs. In some cases, including P. falciparum and HeLa cells, nuclear staining
appeared more intense than cytoplasmic staining [2,9].
Based on studies with heterologously expressed human
PP5-GFP fusion proteins, it has been proposed that nuclear localization requires a stretch of sequence in the C terminus [31]. However, other sequences or signals are also
likely to contribute to nuclear localization of PP5 and its
homologs, since rat and mouse PP5, which are identical
to human PP5 in this region do not appear to be nuclear
in all cell types [32,33]. In addition P. falciparum PP5 is
primarily nuclear [9], although it is not well conserved in
the relevant C-terminal region but contains a potential bipartite nuclear localization signal not found in other PP5
sequences reported thus far. The functional significance of
differential localization is not known at this time.
Ppt1p levels are highest during periods of rapid growth
and drop off when growth slows (Fig. 4B), raising the possibility that this enzyme may have a role in controlling cell
growth [34] and its expression may be regulated by a metabolic or nutritional signal [35]. The observation that
Ppt1p levels rose and fell in parallel with mRNA levels
suggests that Ppt1p expression is primarily controlled at
the level of gene transcription. Studies of PP5 and its homologs in cultured cells and various organisms also suggest it may play a role in development [5,6] or during
rapid cell growth [2,7].

Conclusions
Ppt1p shares several biochemical properties with PP5 and
other homologs, including a similar domain structure and
stimulation by lipid in vitro. Unlike PP5, Ppt1p is not fully
activated by removal of the TPR domain or by removal of
9 C-terminal residues, suggesting that these regions may
not play an autoinhibitory role in Ppt1p. Ppt1p is expressed in early log phase growth and decreases dramatically as cells approach the stationary phase, suggesting
that Ppt1p could play a role in cell growth or may be controlled by metabolic or nutritional signals. Like PP5, the
observation that Ppt1p is localized in both the nucleus
and cytoplasm implies that it may function in several subcellular compartments.
Although our findings suggest some differences may exist
in regulatory properties of Ppt1p and PP5, many biochemical and cellular properties are shared. In addition a
recent report has shown that Ppt1p is co-purified with
Hsp82p and Hsc82p, the S. cerevisiae homologs of hsp90
[36], indicating that Ppt1p and PP5 have at least one common protein partner and suggesting that, like PP5, Ppt1p
functions in chaperone complexes. Thus, S. cerevisiae
Ppt1p is likely to be a valuable model for probing the cellular role of PP5.
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Methods
Materials
Restriction enzymes and DNA modifying enzymes were
purchased from New England Biolabs, Promega or Gibco
BRL. Reagents for bacterial and yeast culture were purchased from Difco. All other materials were from Sigma
unless otherwise noted. The yeast centromeric plasmid
encoding the Spc42p-EGFP fusion protein was a kind gift
from Younghoon Oh and Dr. Harry Charbonneau (Department of Biochemistry, Purdue University).
Cloning and expression of recombinant Ppt1p, Ppt1p (1–
504), and PP5 in E. coli
PP5 was expressed and purified as described previously
[18]. To generate the expression plasmid pET-GST-PPT1,
Saccharomyces cerevisiae genomic DNA was used as template in a polymerase chain reaction (PCR) with PPT1specific oligonucleotide primers, (5' primer, 5'-ATGtcaacacccacagcagcagat; 3' primer, 5'-CTAtaaaccaaaaccaccattagaa) that contained initiation and stop codons,
respectively. A PCR product containing the full-length
PPT1 coding region was then cloned into the EcoRV restriction site of pBII KS – (Stratagene) and sequenced. A
fragment containing the PPT1 ORF was excised from the
pBII-PPT1 using EcoRI and XhoI restriction enzymes and
was subcloned downstream of the GST coding region into
the EcoRI and SalI sites of the bacterial expression vector
pET-21a GST [37]. To construct the pET-GST-PPT1 (1–
504) plasmid a 453 bp fragment was amplified from pETGST-PPT1 by PCR using a 3' primer containing a XhoI restriction site and a stop codon designed to truncate the
PPT1 gene product at Met504 (5'-gatcctcgagTTAcattggttttatatctggg) and a 5' primer (5'-gtaatgcatggtggttta) encompassing the NsiI restriction site of PPT1. The PCR product
was cloned into the NsiI and XhoI restriction sites of pETGST-PPT1 and sequenced. Each construct was transformed into E. coli strain BL21 (DE3) (Novagen), and protein was expressed, purified by glutathione-agarose
affinity chromatography, cleaved from GST and stored in
20 mM Tris (pH 7.6 at 4°C), 50% glycerol, 1 mM EGTA,
0.1% 2-mercaptoethanol, 4 mM MnCl2 at -20°C as previously described for PP5 [18]. Recombinant Ppt1p and
Ppt1p (1–504) each contain an additional seven residues,
Gly-Ser-Gly-Ser-Glu-Phe-Asp, which are remnants of the
thrombin-cleavage site. SDS-PAGE and Coomassie
stained gels showed that full-length Ppt1p and Ppt1p (1–
504) each constituted more than 95% of the purified protein (Fig. 1A).
Phosphatase assays
32P-labeled substrates were prepared and assays performed as described previously [18]. Briefly, protein phosphatase reactions contained 2 or 4 nM enzyme in a final
volume of 30 µl containing buffer A (50 mM Tris, pH 7.6,
1 mM EDTA, 1 mM EGTA, 0.1% 2-mercaptoethanol),
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0.4% ethanol and 10 µM radiolabeled phosphosubstrate
in the absence or presence of AA [19]. Reactions were initiated by adding substrate and lipid, and incubated at
30°C for 10 to 15 min. The phosphate released from each
substrate was less than 20% of the total present. The
amount of ethanol added to lipid-stimulated or control
samples had no effect on activity.
Limited proteolysis of Ppt1p
Recombinant protein was incubated with either trypsin
(Roche Molecular Biochemicals) or subtilisin (Roche Molecular Biochemicals) in the absence or presence of 250
µM lipid for 0 to 30 min at 30°C, as previously described
[19]. To assess phosphatase activity, an aliquot of the digestion reaction was diluted in buffer A containing either
0.1 mg/ml soybean trypsin inhibitor for trypsin, or 2 mM
PMSF for subtilisin and assayed. Matched samples from
the proteolysis reaction were quenched with trichloroacetic acid (10%, w/v), protein was sedimented, then boiled
in (75 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 0.1%
2-mercaptoethanol and 0.01% bromophenol blue), subjected to SDS-PAGE using 10 or 15% resolving gels, and
protein bands visualized by Coomassie staining. For zero
time points, samples were withdrawn before the addition
of protease but were otherwise identical.
N-terminal sequence analysis of proteolytic fragments
Proteolytic fragments separated by SDS-PAGE were transferred to ProBlott PVDF membranes (Applied Biosystems,
Inc.) as described by LeGendre et al [38]. Coomassiestained protein bands were then subjected to sequence
analysis using either a Model 491 or Model 470A gas
phase sequencer equipped with a Model 120A on-line
phenylthiohydantoin analyzer (Applied Biosystems, Inc).
Sequence analysis was performed in the Purdue Macromolecular Structure Facility.
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genomic DNA by PCR using a 5' primer containing a KpnI
restriction site (5'-gatcGGTACCattagcacggtgccttaacca-3')
and a 3' primer containing a XhoI site and HA coding sequence
(5'gatcCTCGAGatcgataccgtcgagctagcgtagtctgggacgtcgtatgggta
tcgactcatATTCGAGATATTTGATTATACCAAGGC-3'). In
the 3' primer, the sequence from the XhoI restriction site
to the HA coding sequence was identical to that present in
YCpIF16. The amplified DNA fragment was cloned into
pRS306 (New England Biolabs, Inc.) using KpnI and XhoI
restriction sites to generate pRS306-955HA. Then, a fragment containing the PPT1 ORF was excised from
YCpIF16-PPT1 by XhoI and NotI digestion and subcloned
into this plasmid to form pRS306-955HAPPT1. The plasmid was linearized by BamHI digestion, transformed into
the yeast strain, W303, and the transformed cells were
plated on a SC-Ura plate. The resulting colonies were then
grown in YPAD media (1% yeast extract, 2% peptone,
0.04% adenine, and 2% glucose) and plated on 5-FOA
plates to select clones emerging by a second recombination event that eliminated the URA3 gene together with
the additional copy of PPT1. To confirm gene replacement, chromosomal DNA from these clones was used for
PCR amplification of the region encoding HA-Ppt1p. Amplified product was then analyzed by XhoI digest, which
can only cut amplified product from the replaced gene.

Cloning, subcloning, and gene replacement for the expression of HA-Ppt1p in yeast cells
For expression of HA-tagged Ppt1p under control of the
GAL1 promoter, a PPT1 DNA fragment was cut from pETGST-PPT1 by EcoRI and NotI digestion and subcloned into
the EcoRI/NotI-digested YCpIF16 (ATCC No. 87091), a
centromeric plasmid. The resulting plasmid, YCpIF16PPT1, was transformed into yeast W303 cells (MATa,
can1-100, leu2-3,112, his3-11,15, trp1-1, ura3-1, ade2-1).
Transformed cells were grown in SC-Trp medium at 30°C
to OD600 nm 0.5, washed twice to remove glucose, then
grown in SG-Trp medium containing 2% galactose instead of glucose for 12–16 hr at room temperature to induce protein expression.

Immunoblotting and immunocytochemical analysis of HAPpt1p expression
Wild type (W303) cell and WHT4-1 cells were grown in
YPAD medium. The expression of HA-Ppt1p was detected
by immunoblot using the 12CA5 monoclonal anti-HA
antibody (Roche Molecular Biochemicals). The total protein was extracted from approximately 107 cells by vortexing with glass beads, then resolved by SDS-PAGE on 12%
gel, and transferred to nitrocellulose at 55V in (25 mM
Tris, 250 mM glycine, 0.1% SDS, and 20% methanol) for
1 hr at room temperature. The membrane was blocked
with 3% non-fat dry milk (Bio-Rad), 0.1% tween-20 in
TBS (pH 7.4), then cut at molecular weight marker 45
kDa. The upper half was probed with anti-HA antibody (4
µg/ml), followed by HRP-conjugated anti-mouse IgG
(1:5,000, CalBiochem), and the signal was detected using
ECL reagents (Amersham Pharmacia Biotech UK Ltd.).
The lower half was probed with anti-Cdc28p antibody
(Santa Cruz Biotechnology) to ensure that an equal
amount of protein was loaded in each lane. The relative
level of HA-Ppt1p expression was determined by comparing the band intensity of HA-Ppt1p to that of Cdc28p using ImageQuant software version 5.1 (Molecular
Dynamics).

A strain expressing HA-Ppt1p was made using the twostep gene replacement strategy [39]. First, the upstream sequence of PPT1 (-955 to -1) was amplified from yeast

Cells were prepared for immunocytochemistry as described by Harlow and Lane [40]. Briefly, WHT4-1 cells
were grown to early log-phase (OD600 nm 1.0–1.5), fixed
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by 4% para-formaldehyde, and the cell wall was removed
by treatment with β-glucuronidase and zymolase. The resulting spheroplasts were attached to poly-L-lysine coated
coverslips and treated with cold methanol, then acetone.
After blocking non-specific binding sites with 3% BSA,
0.1% tween-20 in PBS, the coverslips were incubated with
anti-HA (40 µg/ml) or anti-GFP antibody (40 µg/ml), rabbit anti-mouse IgG (Pierce, 1:200), biotin-conjugated
anti-rabbit IgG (Vector Laboratories, 1:200), and streptavidin conjugated with either Alexa 488 or Alexa 594 (Molecular Probes, 1:200). After staining nuclei with 4'6diamidino-2-phenylindole (DAPI), the coverslips were
mounted on slides using ProLong anti-fade reagent (Molecular Probes). The specimens were examined with a
BX60 fluorescence microscope (Olympus) and images
captured using a RT220 color digital camera (Diagnostic
Instruments, Inc.). W303 cells treated in the same manner
were used as a negative control.
Northern blot analysis of PPT1 mRNA
Total RNA was prepared from W303 and WHT4-1 yeast
cells using hot acid phenol extraction [41]. For electrophoresis, 20 µg of RNA per sample was resolved on a 1%
agarose gel containing 2.2 M formaldehyde at 5V/cm until
the bromophenol blue migrated 8 cm. The gel was rinsed
with diethylpyrocarbonate-treated H2O and the RNA was
transferred to a Hybond N+ membrane (Amersham Biosciences) by capillary transfer in alkaline solution (0.01 N
NaOH, 3 M NaCl) for overnight. The membrane was prehybridized with PERFECTHYB PLUS solution (Sigma) at
68°C for 1 hr, and a cDNA probe for PPT1 was added and
incubated at 42°C for overnight. The cDNA probe was
prepared by restriction digestion of pET-GST-PPT1 with
BsmI and NcoI. The 879 bp DNA fragment generated, corresponding to 544–1422 of PPT1 coding sequence, was
gel-purified and labeled with 0.67 µM [α-32P] CTP (3000
Ci/mmol) using the DECAprimeII random priming kit
(Ambion) according to the user manual. After washing
with 1 × SSC, 0.1% SDS for 20 min at room temperature
and 0.2 × SSC, 0.1% SDS for 20 min three times at 68°C,
the membrane was exposed to a storage phosphor screen
GP (Kodak) or x-ray film (BMS 1, Kodak). The membrane
was stripped in 50% formamide, 0.1 × SSC, 0.1% SDS for
2 hr at 68°C, and reprobed with a cDNA for ACT1 (yeast
actin gene). The DNA fragment corresponding 214–694
of actin coding sequence was amplified by PCR using
yeast genomic DNA as template and ACT1-specific oligonucleotide primers (5' primer, 5'-gaacacggtattgtcaccaactgggacgatatgg;
3'
primer,
5'gagcagcggtttgcatttcttgttcgaagtcc). The 481 bp DNA fragment was labeled and used essentially as described for the
PPT1 probe. The storage phosphor screen was scanned using Typhoon scanner (Molecular Dynamics), and the relative level of PPT1 message was determined by comparing
the band intensity of PPT1 mRNA to that of actin mRNA
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using ImageQuant software version 5.1 (Molecular
Dynamics).
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hemagglutinin.
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